CAS 366017-09-6 appears in our catalog under these names: Mubritinib/ 99.87% (existing batch purity), Mubritinib (TAK 165), Mubritinib, >98.0%(HPLC), Mubritinib, Mubritinib 98%. Offered by: TargetMol, GLPBio, TCI, Biosynth, Ambeed. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10mM/1mL, 25 mg.
Mubritinib has been used in trials studying the treatment of Lung Neoplasm, Renal Neoplasm, Breast Neoplasm, Ovarian Neoplasm, and Pancreatic Neoplasm.
Source: ChEBI
| Molecular formula | C25H23F3N4O2 |
|---|---|
| Molecular weight | 468.5 g/mol |
| IUPAC name | 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole |
| InChIKey | ZTFBIUXIQYRUNT-MDWZMJQESA-N |
| SMILES | C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)/C=C/C4=CC=C(C=C4)C(F)(F)F |
Computed by PubChem (NCBI)